BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Block SL, Doern GV, Pfaller MA. Oral β-lactams in the treatment of acute otitis media. Diagnostic Microbiology and Infectious Disease 2007;57:S19-30. [DOI: 10.1016/j.diagmicrobio.2007.01.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Fenoll A, Aguilar L, Robledo O, Giménez MJ, Tarragó D, Granizo JJ, Gimeno M, Coronel P. Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media. J Antimicrob Chemother. 2007;60:323-327. [PMID: 17562681 DOI: 10.1093/jac/dkm209] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
2 Hadley JA, Fritsche TR. The role of newer orally administered cephalosporins in contemporary outpatient practice. Diagnostic Microbiology and Infectious Disease 2007;57:S1-3. [DOI: 10.1016/j.diagmicrobio.2006.12.013] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
3 Wald ER, Demuri GP. COMMENTARY: Antibiotic Recommendations for Acute Otitis Media and Acute Bacterial Sinusitis in 2013—The Conundrum. Pediatric Infectious Disease Journal 2013;32:641-3. [DOI: 10.1097/inf.0b013e3182868cc8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]